Showing results (321-330 of 378) with videos related to
Sort By:
Pageof 38
The Journal of Experimental Medicine|June 22, 2016
Targeting MTHFD2 in acute myeloid leukemiaYana Pikman, Alexandre Puissant, Gabriela Alexe, et al.The Journal of Clinical Investigation|August 8, 2009
HIF2alpha cooperates with RAS to promote lung tumorigenesis in miceWilliam Y Kim, Samanthi Perera, Bing Zhou, et al.Cancer Cell|October 6, 2009
Proteomic and genetic approaches identify Syk as an AML targetCynthia K Hahn, Jacob E Berchuck, Kenneth N Ross, et al.The Journal of Clinical Investigation|February 14, 2012
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemiaVersha Banerji, Stacey M Frumm, Kenneth N Ross, et al.Med (New York, N.Y.)|October 4, 2022
Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumorsDiego F Coutinho, Prabhjot S Mundi, Lianna J Marks, et al.Nature Medicine|June 12, 2012
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemiaAlex Kentsis, Casie Reed, Kim L Rice, et al.Cancer Research|October 19, 2010
Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogeneZhao Chen, Takaaki Sasaki, Xiaohong Tan, et al.Blood|March 20, 2010
Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutantsEllen Weisberg, Hwan Geun Choi, Arghya Ray, et al.Cancer Research|March 31, 2011
Differentiation of NUT midline carcinoma by epigenomic reprogrammingBrian E Schwartz, Matthias D Hofer, Madeleine E Lemieux, et al.Nature Medicine|October 1, 2013
Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunitiesMariella Gruber Filbin, Sukriti K Dabral, Maria F Pazyra-Murphy, et al.Pageof 38